Serum intestinal-fatty acid binding protein as a biomarker for refractory celiac disease

Authors

  • Sascha Gross Department of Pathology, VU University Medical Centre, Amsterdam,
  • Marlou P. M. Adriaanse Department of Paediatrics & Nutrition and Toxicology Research Institute Maastricht (NUTRIM), Maastricht University Medical Centre, Maastricht, The Netherlands
  • Petula Nijeboer Department of Gastroenterology and Hepatology, VU University Medical Centre, Amsterdam, The Netherlands
  • Greetje J. Tack Department of Gastroenterology and Hepatology, VU University Medical Centre, Amsterdam, The Netherlands
  • Ingrid M.W. van Hoogstraten Department of Pathology, VU University Medical Centre, Amsterdam, The Netherlands
  • Gerd Bouma Department of Gastroenterology and Hepatology, VU University Medical Centre, Amsterdam, The Netherlands
  • Chris J. Mulder Department of Gastroenterology and Hepatology, VU University Medical Centre, Amsterdam, The Netherlands
  • B. Mary E. von Blomberg Department of Pathology, VU University Medical Centre, Amsterdam, The Netherlands
  • Anita C. E. Vreugdenhil Department of Paediatrics & Nutrition and Toxicology Research Institute Maastricht (NUTRIM), Maastricht University Medical Centre, Maastricht, The Netherlands
  • Hetty J. Bontkes Department of Pathology, VU University Medical Centre, Amsterdam, The Netherlands

Keywords:

.

Abstract

.

Downloads

Published

2015-06-01

How to Cite

1.
Gross S, Adriaanse MPM, Nijeboer P, Tack GJ, van Hoogstraten IM, Bouma G, Mulder CJ, von Blomberg BME, Vreugdenhil ACE, Bontkes HJ. Serum intestinal-fatty acid binding protein as a biomarker for refractory celiac disease. JGLD [Internet]. 2015 Jun. 1 [cited 2026 Jan. 14];24(2):257-9. Available from: https://jgld.ro/jgld/index.php/jgld/article/view/1231

Issue

Vol. 24 No. 2: June 2015

Section

Letters